Organon (OGN) EPS (Basic) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Organon (OGN) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | -0.10% |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 284.05% |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -130.68% |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -15.94% |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 39.99% |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 13.91% |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | -26.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.28% |
| Mar 31, 2026 | 66.20% |
| Dec 31, 2025 | -286.30% |
| Sep 30, 2025 | -55.86% |
| Jun 30, 2025 | -26.40% |
| Mar 31, 2025 | -57.08% |
| Dec 31, 2024 | -80.18% |
| Sep 30, 2024 | 514.37% |
| Jun 30, 2024 | -20.03% |
| Mar 31, 2024 | 12.98% |
| Dec 31, 2023 | 2.94% |
| Sep 30, 2023 | -74.57% |
| Jun 30, 2023 | 2.88% |
| Mar 31, 2023 | -49.30% |
| Dec 31, 2022 | 160.83% |
| Sep 30, 2022 | -29.95% |
| Jun 30, 2022 | -45.31% |
| Mar 31, 2022 | -12.80% |
| Dec 31, 2021 | -45.11% |
| Sep 30, 2021 | -40.95% |